1. ChangEB, SitrinMD, BlackDD. Gastrointestinal, Hepatobiliary, and Nutritional Physiology. Philadelphia: Lippincott‐Raven; 1996.

2. TreemWR. Congenital sucrase‐isomaltase deficiency. J Pediatr Gastroenterol Nutr1995;21:1. CrossRef

3. LebenthalE, Khin‐MaungU, ZhengBY, et al.Small intestinal glucoamylase deficiency and starch malabsorption: a newly recognized alpha‐glucosidase deficiency in children. J Pediatr1994;124:541. CrossRef

4. KarnsakulW, LuginbuehlU, HahnD, et al.Disaccharidase activities in dyspeptic children: biochemical and molecular investigations of maltase‐glucoamylase activity. J Pediatr Gastroenterol Nutr2002;35:551. CrossRef

5. TanK, TesarC, WiltonR, et al.Novel ‐glucosidase from human gut microbiome: substrate specificities and their switch. FASEB J2010;24:3939. CrossRef

6. FransenJA, HauriHP, GinselLA, et al.Naturally occurring mutations in intestinal sucrase‐isomaltase provide evidence for the existence of an intracellular sorting signal in the isomaltase subunit. J Cell Biol1991;115:45. CrossRef

7. NaimHY, RothJ, SterchiEE, et al.Sucrase‐isomaltase deficiency in humans. Different mutations disrupt intracellular transport, processing, and function of an intestinal brush border enzyme. J Clin Invest1988;82:667. CrossRef

8. OuwendijkJ, MoolenaarCE, PetersWJ, et al.Congenital sucrase‐isomaltase deficiency. Identification of a glutamine to proline substitution that leads to a transport block of sucrase‐isomaltase in a pre‐Golgi compartment. J Clin Invest1996;97:633. CrossRef

9. NaimHY, HeineM, ZimmerK‐P. Congenital sucrase‐isomaltase deficiency: heterogeneity of inheritance, trafficking, and function of an intestinal enzyme complex. J Pediatr Gastroenterol Nutr2012;55(Suppl 2):S13. CrossRef

10. SpodsbergN, JacobR, AlfalahM, et al.Molecular basis of aberrant apical protein transport in an intestinal enzyme disorder. J Biol Chem2001;276:23506. CrossRef

11. JacobR, ZimmerKP, SchmitzJ, et al.Congenital sucrase‐isomaltase deficiency arising from cleavage and secretion of a mutant form of the enzyme. J Clin Invest2000;106:281. CrossRef

12. WeijersHA, va de KamerJH, MosselDA, et al.Diarrhoea caused by deficiency of sugar‐splitting enzymes. Lancet1960;2:296. CrossRef

13. GodaT, KoldovskyO. Dietary regulation of small intestinal disaccharidases. World Rev Nutr Diet1988;57:275. CrossRef

14. YehKY, YehM, HoltPR. Differential effects of thyroxine and cortisone on jejunal sucrase expression in suckling rats. Am J Physiol1989;256:G604.

15. TundisR, LoizzoMR, MenichiniF. Natural products as alpha‐amylase and alpha‐glucosidase inhibitors and their hypoglycaemic potential in the treatment of diabetes: an update. Mini Rev Med Chem2010;10:315. CrossRef

16. TreemWR. Clinical aspects and treatment of congenital sucrase‐isomaltase deficiency. J Pediatr Gastroenterol Nutr2012;55(Suppl 2):S7. CrossRef

17. Robayo‐TorresCC, Quezada‐CalvilloR, NicholsBL. Disaccharide digestion: clinical and molecular aspects. Clin Gastroenterol Hepatol2006;4:276. CrossRef

18. UhrichS, WuZ, HuangJ‐Y, et al.Four mutations in the SI gene are responsible for the majority of clinical symptoms of CSID. J Pediatr Gastroenterol Nutr2012;55(Suppl 2):S34. CrossRef

19. WelshJD, PoleyJR, BhatiaM, et al.Intestinal disaccharidase activities in relation to age, race, and mucosal damage. Gastroenterology1978;75:847.

20. BellRR, DraperHH, BerganJG. Sucrose, lactose, and glucose tolerance in northern Alaskan Eskimos. Am J Clin Nutr1973;26:1185.

21. Gudmand‐HoyerE, FengerHJ, Kern‐HansenP, et al.Sucrase deficiency in Greenland. Incidence and genetic aspects. Scand J Gastroenterol1987;22:24. CrossRef

22. SmithJA, MayberryJF, AnsellID, et al.Small bowel biopsy for disaccharidase levels: evidence that endoscopic forceps biopsy can replace the Crosby capsule. Clin Chim Acta1989;183:317. CrossRef

23. LevittMD. Production and excretion of hydrogen gas in man. N Engl J Med1969;281:122. CrossRef

24. CallowayDH, MurphyEL, BauerD. Determination of lactose intolerance by breath analysis. Am J Dig Dis1969;14:811. CrossRef

25. Robayo‐TorresCC, OpekunAR, Quezada‐CalvilloR, et al.13C‐breath tests for sucrose digestion in congenital sucrase isomaltase‐deficient and sacrosidase‐supplemented patients. J Pediatr Gastroenterol Nutr2009;48:412. CrossRef

26. HarmsHK, Bertele‐HarmsRM, Bruer‐KleisD. Enzyme‐substitution therapy with the yeast Saccharomyces cerevisiae in congenital sucrase‐isomaltase deficiency. N Engl J Med1987;316:1306. CrossRef

27. TreemWR, AhsanN, SullivanB, et al.Evaluation of liquid yeast‐derived sucrase enzyme replacement in patients with sucrase‐isomaltase deficiency. Gastroenterology1993;105:1061.

28. CampbellAK, WaudJP, MatthewsSB. The molecular basis of lactose intolerance. Sci Prog2009;92:241. CrossRef

29. SwallowDM. Genetics of lactase persistence and lactose intolerance. Annu Rev Genet2003;37:197. CrossRef

30. IngramCJE, ElaminMF, MulcareCA, et al.A novel polymorphism associated with lactose tolerance in Africa: multiple causes for lactase persistence?Hum Genet2007;120:779. CrossRef

31. IngramCJE, MulcareCA, ItanY, et al.Lactose digestion and the evolutionary genetics of lactase persistence. Hum Genet2009;124:579. CrossRef

32. MattarR, de Campos MazoDF, CarrilhoFJ. Lactose intolerance: diagnosis, genetic, and clinical factors. Clin Exp Gastroenterol2012;5:113. CrossRef

33. EnattahNS, SahiT, SavilahtiE, et al.Identification of a variant associated with adult‐type hypolactasia. Nat Genet2002;30:233. CrossRef

34. RasinperaH, KuokkanenM, KolhoK‐L, et al.Transcriptional downregulation of the lactase (LCT) gene during childhood. Gut2005;54:1660. CrossRef

35. Robayo‐TorresCC, NicholsBL. Molecular differentiation of congenital lactase deficiency from adult‐type hypolactasia. Nutr Rev2007;65:95. CrossRef

36. LewinskyRH, JensenTGK, MollerJ, et al.T‐13910 DNA variant associated with lactase persistence interacts with Oct‐1 and stimulates lactase promoter activity in vitro. Hum Mol Genet2005;14:3945. CrossRef

37. EnattahNS, JensenTGK, NielsenM, et al.Independent introduction of two lactase‐persistence alleles into human populations reflects different history of adaptation to milk culture. Am J Hum Genet2008;82:57. CrossRef

38. TishkoffSA, ReedFA, RanciaroA, et al.Convergent adaptation of human lactase persistence in Africa and Europe. Nat Genet2007;39:31. CrossRef

39. OldsLC, SibleyE. Lactase persistence DNA variant enhances lactase promoter activity in vitro: functional role as a cis regulatory element. Hum Mol Genet2003;12:2333. CrossRef

40. HauriHP, SterchiEE, BienzD, et al.Expression and intracellular transport of microvillus membrane hydrolases in human intestinal epithelial cells. J Cell Biol1985;101:838. CrossRef

41. TorniainenS, FreddaraR, RoutiT, et al.Four novel mutations in the lactase gene (LCT) underlying congenital lactase deficiency (CLD). BMC Gastroenterol2009;9:8. CrossRef

42. KuokkanenM, MyllyniemiM, VauhkonenM, et al.A biopsy‐based quick test in the diagnosis of duodenal hypolactasia in upper gastrointestinal endoscopy. Endoscopy2006;38:708. CrossRef

43. NewcomerAD, McGillDB, ThomasPJ, et al.Prospective comparison of indirect methods for detecting lactase deficiency. N Engl J Med1975;293:1232. CrossRef

44. TagCG, OberkaninsC, KriegshauserG, et al.Evaluation of a novel reverse‐hybridization StripAssay for typing DNA variants useful in diagnosis of adult‐type hypolactasia. Clin Chim Acta2008;392:58. CrossRef

45. WeiskirchenR, TagCG, MengsteabS, et al.Pitfalls in LightCycler diagnosis of the single‐nucleotide polymorphism 13.9 kb upstream of the lactase gene that is associated with adult‐type hypolactasia. Clin Chim Acta2007;384:93. CrossRef

46. LindquistB, MeeuwisseGW. Chronic diarrhoea caused by monosaccharide malabsorption. Acta Paediatr1962;51:674. CrossRef

47. SchneiderAJ, KinterWB, StirlingCE. Glucose‐galactose malabsorption. Report of a case with autoradiographic studies of a mucosal biopsy. N Engl J Med1966;274:305. CrossRef

48. WrightEM. I. Glucose galactose malabsorption. Am J Physiol1998;275:G879.

49. HedigerMA, TurkE, WrightEM. Homology of the human intestinal Na+/glucose and Escherichia coli Na+/proline cotransporters. Proc Natl Acad Sci U S A1989;86:5748. CrossRef

50. TurkE, ZabelB, MundlosS, et al.Glucose/galactose malabsorption caused by a defect in the Na+/glucose cotransporter. Nature1991;350:354. CrossRef

51. VallaeysL, BiervlietS, BruynG, et al.Congenital glucose–galactose malabsorption: a novel deletion within the SLC5A1 gene. Eur J Pediatr2012;172:409. CrossRef

52. MontesRG, GottalRF, BaylessTM, et al.Breath hydrogen testing as a physiology laboratory exercise for medical students. Am J Physiol1992;262:S25.

53. AnderssonDE, NygrenA. Four cases of long‐standing diarrhoea and colic pains cured by fructose‐free diet–a pathogenetic discussion. Acta Med Scand1978;203:87. CrossRef

54. KyawMH, MayberryJF. Fructose malabsorption: true condition or a variance from normality. J Clin Gastroenterol2011;45:16. CrossRef

55. BaroneS, FussellSL, SinghAK, et al.Slc2a5 (Glut5) is essential for the absorption of fructose in the intestine and generation of fructose‐induced hypertension. J Biol Chem2009;284:5056. CrossRef

56. DeBoschBJ, ChiM, MoleyKH. Glucose transporter 8 (GLUT8) regulates enterocyte fructose transport and global mammalian fructose utilization. Endocrinology2012;153:4181. CrossRef

57. JonesHF, ButlerRN, BrooksDA. Intestinal fructose transport and malabsorption in humans. Am J Physiol Gastrointest Liver Physiol2011;300:G202. CrossRef

58. RaoSSC, AttaluriA, AndersonL, et al.Ability of the normal human small intestine to absorb fructose: evaluation by breath testing. Clin Gastroenterol Hepatol2007;5:959. CrossRef

59. Wilder‐SmithCH, MaternaA, WermelingerC, et al.Fructose and lactose intolerance and malabsorption testing: the relationship with symptoms in functional gastrointestinal disorders. Aliment Pharmacol Ther2013;37:1074. CrossRef

60. SanterR, SchneppenheimR, SuterD, et al.Fanconi‐Bickel syndrome–the original patient and his natural history, historical steps leading to the primary defect, and a review of the literature. Eur J Pediatr1998;157:783. CrossRef

61. FanconiG, BickelH. Die chronische Aminoacidurie (Aminosäurediabetes oder nephrotisch‐glukosurischer Zwerg‐ wuchs) bei der Glykogenose und der Cystinkrankheit. Helv Paediatr Acta1949;4:359.

62. SanterR, SchneppenheimR, DombrowskiA, et al.Mutations in GLUT2, the gene for the liver‐type glucose transporter, in patients with Fanconi‐Bickel syndrome. Nat Genet1997;17:324. CrossRef

63. RandWM, PellettPL, YoungVR. Meta‐analysis of nitrogen balance studies for estimating protein requirements in healthy adults. Am J Clin Nutr2003;77:109.

64. EricksonRH, KimYS. Digestion and absorption of dietary protein. Annu Rev Med1990;41:133. CrossRef

65. GhishanFK, LeePC, LebenthalE, et al.Isolated congenital enterokinase deficiency. Recent findings and review of the literature. Gastroenterology1983;85:727.

66. HolzingerA, MaierEM, BuckC, et al.Mutations in the proenteropeptidase gene are the molecular cause of congenital enteropeptidase deficiency. Am J Hum Genet2002;70:20. CrossRef

67. TownesPL. Trypsinogen deficiency disease. J Pediatr1965;66:275. CrossRef

68. BaronDN, DentCE, HarrisH, et al.Hereditary pellagra‐like skin rash with temporary cerebellar ataxia, constant renal amino‐aciduria, and other bizarre biochemical features. Lancet1956;271:421. CrossRef

69. KletaR, RomeoE, RisticZ, et al.Mutations in SLC6A19, encoding B0AT1, cause Hartnup disorder. Nat Genet2004;36:999. CrossRef

70. SeowHF, BroerS, BroerA, et al.Hartnup disorder is caused by mutations in the gene encoding the neutral amino acid transporter SLC6A19. Nat Genet2004;36:1003. CrossRef

71. AzmanovDN, KowalczukS, RodgersH, et al.Further evidence for allelic heterogeneity in Hartnup disorder. Hum Mutat2008;29:1217. CrossRef

72. Anon. Treatment of Hartnup disease with nicotinic acid. Nutr Rev1984;42:251.

73. CheonCK, LeeBH, KoJM, et al.Novel mutation in SLC6A19 causing late‐onset seizures in Hartnup disorder. Pediatr Neurol2010;42:369. CrossRef

74. de BaulnyHO, SchiffM, Dionisi‐ViciC. Lysinuric protein intolerance (LPI): a multi organ disease by far more complex than a classic urea cycle disorder. Mol Genet Metab2012;106:12. CrossRef

75. SperandeoMP, AndriaG, SebastioG. Lysinuric protein intolerance: update and extended mutation analysis of theSLC7A7 gene. Hum Mutat2007;29:14. CrossRef

76. SimellO, PerheentupaJ, RapolaJ, et al.Lysinuric protein intolerance. Am J Med1975;59:229. CrossRef

77. BroerS. Lysinuric protein intolerance: one gene, many problems. AJP: Cell Physiology2007;293:C540. CrossRef

78. PartoK, PenttinenR, ParonenI, et al.Osteoporosis in lysinuric protein intolerance. J Inherit Metab Dis1993;16:441. CrossRef

79. EspositoV, LettieroT, FecarottaS, et al.Growth hormone deficiency in a patient with lysinuric protein intolerance. Eur J Pediatr2006;165:763. CrossRef

80. SebastioG, SperandeoMP, AndriaG. Lysinuric protein intolerance: reviewing concepts on a multisystem disease. Am J Med Genet C Semin Med Genet2011;157:54. CrossRef

81. SumorokN, GoldfarbDS. Update on cystinuria. Curr Opin Nephrol Hypertens2013;22:427. CrossRef

82. ChillarónJ, Font‐LlitjosM, FortJ, et al.Pathophysiology and treatment of cystinuria. Nat Rev Nephrol2010;6:424. CrossRef

83. DrummondKN, MichaelAF, UlstromRA, et al.The blue diaper syndrome: familial hypercalcemia with nephrocalcinosis and indicanuria; a new familial disease, with definition of the metabolic abnormality. Am J Med1964;37:928. CrossRef

84. AbumradNA, DavidsonNO. Role of the gut in lipid homeostasis. Physiol Rev2012;92:1061. CrossRef

85. Berriot‐VaroqueauxN, AggerbeckLP, Samson‐BoumaM, et al.The role of the microsomal triglygeride transfer protein in abetalipoproteinemia. Annu Rev Nutr2000;20:663. CrossRef

86. WetterauJR, AggerbeckLP, BoumaME, et al.Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science1992;258:999. CrossRef

87. ShouldersCC, BrettDJ, BaylissJD, et al.Abetalipoproteinemia is caused by defects of the gene encoding the 97 kDa subunit of a microsomal triglyceride transfer protein. Hum Mol Genet1993;2:2109. CrossRef

88. SharpD, BlindermanL, CombsKA, et al.Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemia. Nature1993;365:65. CrossRef

89. MullerDPR. Vitamin E and neurological function. Mol Nutr Food Res2010;54:710. CrossRef

90. GorinMB, PaulTO, RaderDJ. Angioid streaks associated with abetalipoproteinemia. Ophthalmic Genet1994;15:151. CrossRef

91. DukerJS, BelmontJ, BosleyTM. Angioid streaks associated with abetalipoproteinemia. Case report. Arch Ophthalmol1987;105:1173. CrossRef

92. SchonfeldG. Familial hypobetalipoproteinemia: a review. J Lipid Res2003;44:878. CrossRef

93. WeltyFK, LahozC, TuckerKL, et al.Frequency of ApoB and ApoE gene mutations as causes of hypobetalipoproteinemia in the framingham offspring population. Arterioscler Thromb Vasc Biol1998;18:1745. CrossRef

94. TarugiP, AvernaM. Hypobetalipoproteinemia: genetics, biochemistry, and clinical spectrum. Adv Clin Chem2011;54:81. CrossRef

95. PerettiN, SassolasA, RoyCC, et al.Guidelines for the diagnosis and management of chylomicron retention disease based on a review of the literature and the experience of two centers. Orphanet J Rare Dis2010;5:24. CrossRef

96. JonesB, JonesEL, BonneySA, et al.Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders. Nat Genet2003;34:29. CrossRef

97. PerettiN, RoyCC, SassolasA, et al.Chylomicron retention disease: a long term study of two cohorts. Mol Genet Metab2009;97:136. CrossRef

98. RobbBW, MatthewsJB. Bile salt diarrhea. Curr Gastroenterol Rep2005;7:379. CrossRef

99. GelbmannCM, SchteingartCD, ThompsonSM, et al.Mast cells and histamine contribute to bile acid‐stimulated secretion in the mouse colon. J Clin Invest1995;95:2831. CrossRef

100. LowesS, SimmonsNL. Human intestinal cell monolayers are preferentially sensitive to disruption of barrier function from basolateral exposure to cholic acid: correlation with membrane transport and transepithelial secretion. Pflugers Arch2001;443:265. CrossRef

101. HeubiJE, BalistreriWF, FondacaroJD, et al.Primary bile acid malabsorption: defective in vitro ileal active bile acid transport. Gastroenterology1982;83:804.

102. OelkersP, KirbyLC, HeubiJE, et al.Primary bile acid malabsorption caused by mutations in the ileal sodium‐dependent bile acid transporter gene (SLC10A2). J Clin Invest1997;99:1880. CrossRef

103. ThaysenEH, PedersenL. Idiopathic bile acid catharsis. Gut1976;17:965. CrossRef

104. KurienM, EvansKE, LeedsJS, et al.Bile acid malabsorption: an under‐investigated differential diagnosis in patients presenting with diarrhea predominant irritable bowel syndrome type symptoms. Scand J Gastroenterol2011;46:818. CrossRef

105. WaltersJRF, TasleemAM, OmerOS, et al.A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis. Clin Gastroenterol Hepatol2009;7:1189. CrossRef

106. WongBS, CamilleriM, CarlsonP, et al.Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea. Clin Gastroenterol Hepatol2012;10:1009. CrossRef

107. KaplanJ, WardDM, DomenicoI. The molecular basis of iron overload disorders and iron‐linked anemias. Int J Hematol2011;93:14. CrossRef

108. NemethE, TuttleMS, PowelsonJ, et al.Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science2004;306:2090. CrossRef

109. BabittJ, LinH. The molecular pathogenesis of hereditary hemochromatosis. Semin Liver Dis2011;31:280. CrossRef

110. RoettoA, PapanikolaouG, PolitouM, et al.Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet2003;33:21. CrossRef

111. PapanikolaouG, SamuelsME, LudwigEH, et al.Mutations in HFE2 cause iron overload in chromosome 1q‐linked juvenile hemochromatosis. Nat Genet2004;36:77. CrossRef

112. BabittJL, HuangFW, WrightingDM, et al.Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet2006;38:531. CrossRef

113. FernandesA, PrezaGC, PhungY, et al.The molecular basis of hepcidin‐resistant hereditary hemochromatosis. Blood2009;114:437. CrossRef

114. ShamRL, PhatakPD, NemethE, et al.Hereditary hemochromatosis due to resistance to hepcidin: high hepcidin concentrations in a family with C326S ferroportin mutation. Blood2009;114:493. CrossRef

115. NemethE, RoettoA, GarozzoG, et al.Hepcidin is decreased in TFR2 hemochromatosis. Blood2005;105:1803. CrossRef

116. FlemingRE, AhmannJR, MigasMC, et al.Targeted mutagenesis of the murine transferrin receptor‐2 gene produces hemochromatosis. Proc Natl Acad Sci U S A2002;99:10653. CrossRef

117. KawabataH, FlemingRE, GuiD, et al.Expression of hepcidin is down‐regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis. Blood2005;105:376. CrossRef

118. GanE, PowellL, OlynykJ. Natural history and management of HFE‐hemochromatosis. Semin Liver Dis2011;31:293. CrossRef

119. TumerZ, MollerLB. Menkes disease. Eur J Hum Genet2010;18:511. CrossRef

120. ZimnickaAM, MaryonEB, KaplanJH. Human copper transporter hCTR1 mediates basolateral uptake of copper into enterocytes: implications for copper homeostasis. J Biol Chem2007;282:26471. CrossRef

121. ZimnickaAM, IvyK, KaplanJH. Acquisition of dietary copper: a role for anion transporters in intestinal apical copper uptake. AJP: Cell Physiology2011;300:C588. CrossRef

122. PetrisMJ, MercerJF, CulvenorJG, et al.Ligand‐regulated transport of the Menkes copper P‐type ATPase efflux pump from the Golgi apparatus to the plasma membrane: a novel mechanism of regulated trafficking. EMBO J1996;15:6084.

123. TonnesenT, KleijerWJ, HornN. Incidence of Menkes disease. Hum Genet1991;86:408. CrossRef

124. GuYH, KodamaH, ShigaK, et al.A survey of Japanese patients with Menkes disease from 1990 to 2003: incidence and early signs before typical symptomatic onset, pointing the way to earlier diagnosis. J Inherit Metab Dis2005;28:473. CrossRef

125. KodamaH, FujisawaC, BhadhprasitW. Inherited copper transport disorders: biochemical mechanisms, diagnosis, and treatment. Curr Drug Metab2012;13:237. CrossRef

126. Kotula‐BalakM, LenartowiczM, KowalM, et al.Testicular morphology and expression of aromatase in testes of mice with the mosaic mutation (Atp7a mo‐ms). Theriogenology2007;67:423. CrossRef

127. SarkarB. Treatment of Wilson and menkes diseases. Chem Rev1999;99:2535. CrossRef

128. HuangL, TepaamorndechS. The SLC30 family of zinc transporters – a review of current understanding of their biological and pathophysiological roles. Mol Aspects Med2013;34:548. CrossRef

129. WangX, ZhouB. Dietary zinc absorption: a play of Zips and ZnTs in the gut. IUBMB Life2010;62:176. CrossRef

130. KrebsNF. Overview of zinc absorption and excretion in the human gastrointestinal tract. J Nutr2000;130(5S Suppl):1374S.

131. MaverakisE, FungMA, LynchPJ, et al.Acrodermatitis enteropathica and an overview of zinc metabolism. J Am Acad Dermatol2007;56:116. CrossRef

132. SchmittS, KüryS, GiraudM, et al.An update on mutations of the SLC39A4gene in acrodermatitis enteropathica. Hum Mutat2009;30:926. CrossRef

133. WedenojaS, PekansaariE, HoglundP, et al.Update on SLC26A3 mutations in congenital chloride diarrhea. Hum Mutat2011;32:715. CrossRef

134. HoglundP, AuranenM, SochaJ, et al.Genetic background of congenital chloride diarrhea in high‐incidence populations: Finland, Poland, and Saudi Arabia and Kuwait. Am J Hum Genet1998;63:760. CrossRef

135. HolmbergC. Congenital chloride diarrhoea. Clin Gastroenterol1986;15:583.

136. WedenojaS, Ha GlundP, HolmbergC. Review article: the clinical management of congenital chloride diarrhoea. Aliment Pharmacol Ther2010;31:477. CrossRef

137. AichbichlerBW, ZerrCH, Santa AnaCA, et al.Proton‐pump inhibition of gastric chloride secretion in congenital chloridorrhea. N Engl J Med1997;336:106. CrossRef

138. CananiRB, TerrinG, CirilloP, et al.Butyrate as an effective treatment of congenital chloride diarrhea. Gastroenterology2004;127:630. CrossRef

139. FellJM, MillerMP, FinkelY, et al.Congenital sodium diarrhea with a partial defect in jejunal brush border membrane sodium transport, normal rectal transport, and resolving diarrhea. J Pediatr Gastroenterol Nutr1992;15:112. CrossRef

140. KellerKM, WirthS, BaumannW, et al.Defective jejunal brush border membrane sodium/proton exchange in association with lethal familial protracted diarrhoea. Gut1990;31:1156. CrossRef

141. BoothIW, StangeG, MurerH, et al.Defective jejunal brush‐border Na+/H+ exchange: a cause of congenital secretory diarrhoea. Lancet1985;1:1066. CrossRef

142. HolmbergC, PerheentupaJ. Congenital Na+ diarrhea: a new type of secretory diarrhea. J Pediatr1985;106:56. CrossRef

143. BaumM, MartinMG, BoothIW, et al.Nucleotide sequence of the Na+/H+ exchanger‐8 in patients with congenital sodium diarrhea. J Pediatr Gastroenterol Nutr2011;53:474.

144. Heinz‐ErianP, MullerT, KrabichlerB, et al.Mutations in SPINT2 cause a syndromic form of congenital sodium diarrhea. Am J Hum Genet2009;84:188. CrossRef

145. SuhSM, TashjianAHJ, MatsuoN, et al.Pathogenesis of hypocalcemia in primary hypomagnesemia: normal end‐organ responsiveness to parathyroid hormone, impaired parathyroid gland function. J Clin Invest1973;52:153. CrossRef

146. AnastCS, MohsJM, KaplanSL, et al.Evidence for parathyroid failure in magnesium deficiency. Science1972;177:606. CrossRef

147. SchlingmannKP, WaldeggerS, KonradM, et al.TRPM6 and TRPM7 – Gatekeepers of human magnesium metabolism. Biochim Biophys Acta2007;1772:813. CrossRef

148. MillaPJ, AggettPJ, WolffOH, et al.Studies in primary hypomagnesaemia: evidence for defective carrier‐mediated small intestinal transport of magnesium. Gut1979;20:1028. CrossRef

149. WalderRY, LandauD, MeyerP, et al.Mutation of TRPM6 causes familial hypomagnesemia with secondary hypocalcemia. Nat Genet2002;31:171. CrossRef

150. SchlingmannKP, KonradM, SeyberthHRW. Genetics of hereditary disorders of magnesium homeostasis. Pediatric Nephrology2004;19:13. CrossRef

151. SchlingmannKP. Novel TRPM6 mutations in 21 families with primary hypomagnesemia and secondary hypocalcemia. J Am Soc Nephrol2005;16:3061. CrossRef

152. GellerJ, KronnD, JayaboseS, et al.Hereditary folate malabsorption: family report and review of the literature. Medicine (Baltimore)2002;81:51. CrossRef

153. NielsenMJ, RasmussenMR, AndersenCBF, et al.Vitamin B12 transport from food to the body's cells–a sophisticated, multistep pathway. Nat Rev Gastroenterol Hepatol2012;9:345. CrossRef

154. AllenRH, SeetharamB, PodellE, et al.Effect of proteolytic enzymes on the binding of cobalamin to R protein and intrinsic factor. In vitro evidence that a failure to partially degrade R protein is responsible for cobalamin malabsorption in pancreatic insufficiency. J Clin Invest1978;61:47. CrossRef

155. BirnH, VerroustPJ, NexoE, et al.Characterization of an epithelial approximately 460‐kDa protein that facilitates endocytosis of intrinsic factor‐vitamin B12 and binds receptor‐associated protein. J Biol Chem1997;272:26497. CrossRef

156. FyfeJC, MadsenM, HojrupP, et al.The functional cobalamin (vitamin B12)‐intrinsic factor receptor is a novel complex of cubilin and amnionless. Blood2004;103:1573. CrossRef

157. HallCA. The carriers of native vitamin B12 in normal human serum. Clin Sci Mol Med1977;53:453.

158. QuadrosEV, NakayamaY, SequeiraJM. The protein and the gene encoding the receptor for the cellular uptake of transcobalamin‐bound cobalamin. Blood2009;113:186. CrossRef

159. WatkinsD, RosenblattDS. Inborn errors of cobalamin absorption and metabolism. Am J Med Genet C Semin Med Genet2011;157:33. CrossRef

160. StablerSP. Clinical practice. Vitamin B12 deficiency. N Engl J Med2013;368:149. CrossRef

161. HealtonEB, SavageDG, BrustJC, et al.Neurologic aspects of cobalamin deficiency. Medicine (Baltimore)1991;70:229. CrossRef

162. AdcockBB, McKnightJT. Cobalamin pseudodeficiency due to a transcobalamin I deficiency. South Med J2002;95:1060. CrossRef

163. YassinF, RothenbergSP, RaoS, et al.Identification of a 4‐base deletion in the gene in inherited intrinsic factor deficiency. Blood2004;103:1515. CrossRef

164. TannerSM, AminoffM, WrightFA, et al.Amnionless, essential for mouse gastrulation, is mutated in recessive hereditary megaloblastic anemia. Nat Genet2003;33:426. CrossRef

165. AminoffM, CarterJE, ChadwickRB, et al.Mutations in CUBN, encoding the intrinsic factor‐vitamin B12 receptor, cubilin, cause hereditary megaloblastic anaemia 1. Nat Genet1999;21:309. CrossRef

166. NexoE, Hoffmann‐LuckeE. Holotranscobalamin, a marker of vitamin B‐12 status: analytical aspects and clinical utility. Am J Clin Nutr2011;94:359S. CrossRef

167. NyhanWL. Inborn errors of biotin metabolism. Arch Dermatol1987;123:1696. CrossRef

168. SaidHM. Intestinal absorption of water‐soluble vitamins in health and disease. Biochem J2011;437:357. CrossRef

169. ZempleniJ, KuroishiT. Biotin. Adv Nutr2012;3:213. CrossRef

170. BoschAM, AbelingNGGM, IjlstL, et al.Brown‐Vialetto‐Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: a new inborn error of metabolism with potential treatment. J Inherit Metab Dis2011;34:159. CrossRef

171. ReboulE, BorelP. Proteins involved in uptake, intracellular transport and basolateral secretion of fat‐soluble vitamins and carotenoids by mammalian enterocytes. Prog Lipid Res2011;50:388. CrossRef

172. ReboulE. Absorption of vitamin A and carotenoids by the enterocyte: focus on transport proteins. Nutrients2013;5:3563. CrossRef

173. SeeligerMW, BiesalskiHK, WissingerB, et al.Phenotype in retinol deficiency due to a hereditary defect in retinol binding protein synthesis. Invest Ophthalmol Vis Sci1999;40:3.

174. BorelP, PreveraudD, DesmarchelierC. Bioavailability of vitamin E in humans: an update. Nutr Rev2013;71:319. CrossRef

175. OuahchiK, AritaM, KaydenH, et al.Ataxia with isolated vitamin E deficiency is caused by mutations in the alpha‐tocopherol transfer protein. Nat Genet1995;9:141. CrossRef

176. BorelP, MoussaM, ReboulE, et al.Human plasma levels of vitamin E and carotenoids are associated with genetic polymorphisms in genes involved in lipid metabolism. J Nutr2007;137:2653.

177. RosenCJ. Clinical practice. Vitamin D insufficiency. N Engl J Med2011;364:248. CrossRef

178. ShearerMJ, FuX, BoothSL. Vitamin K nutrition, metabolism, and requirements: current concepts and future research. Adv Nutr2012;3:182. CrossRef

179. GeorgesA, BonneauJ, Bonnefort‐RousselotD, et al.Molecular analysis and intestinal expression of SAR1 genes and proteins in Anderson's disease (Chylomicron retention disease. Orphanet J Rare Dis2011;6:1. CrossRef